Key result
IHD incidence and prevalence decline ~3% annually in New Zealand from 2005 to 2016.
Why the study?
Trends in ischaemic heart disease incidence and prevalence in New Zealand needed examination using comprehensive linked national hospitalization and mortality data.
Observational
Yes
Both incidence and prevalence of ischaemic heart disease have declined in New Zealand from 2005 to 2016 across all age groups and both sexes.
Declining New Zealand IHD trends support sustained prevention efforts; leaves open drivers and generalizability.
Aims To examine trends in ischaemic heart disease (IHD) incidence and prevalence in New Zealand from 2005 to 2016, using comprehensive linked national hospitalization and mortality data as proxy measures of all significant events. Methods and results Incident and prevalent cases of IHD in people aged ≥25 years were identified using individual patient-linkage of routinely collected ICD-10-coded hospitalization and mortality data. Incidence rates and prevalence proportions were calculated by sex and age group and then age-standardized to the 2016 New Zealand population. Ischaemic heart disease incidence and prevalence declined in men and women in all age groups. The average annual rate of decline in age-standardized IHD incidence was 3.3% for women and 2.7% for men, and the rate of decline in age-standardized IHD prevalence was 3.2% for women and 2.2% for men. Despite a 17% increase in the New Zealand population aged 25 years and over during the study period, the total number of people living with IHD also decreased, particularly in those aged 65 years and older. Conclusion In contrast to observations from other countries, where IHD incidence but not IHD prevalence has been falling, declining IHD incidence in New Zealand in recent decades is now mirrored by declining IHD prevalence.
No takes yet. Share an insight, caveat, or question.
Grey et al. (2020) conducted an observational in Ischaemic heart disease. Between 2005 and 2016 in New Zealand, age-standardized ischaemic heart disease incidence declined annually by 3.3% in women and 2.7% in men, with prevalence declining by 3.2% and 2.2% respectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: